Celldex: Preparing To EMERGE RTT News Tue, 01 May 2012 06:03 AM PDT In the United States, the most common cancer among women is breast cancer, and it is the second leading cause of cancer death in women. The American Cancer Society estimates that about 39,510 women will die from breast cancer this year. | African-American breast cancer survivors report inadequate information, options, support services EurekAlert! Tue, 01 May 2012 05:53 AM PDT ( University of California - Davis Health System ) African-American breast cancer survivors were satisfied with their cancer treatment, but most were never offered clinical trials opportunities or support services during or after their treatment, according to a study by a UC Davis Comprehensive Cancer Center researcher and her community partner, Rev. Tammie Dynse. | Health Resources Everett Herald Tue, 01 May 2012 05:53 AM PDT Providence Regional Cancer Partnership: 1717 13th St., Everett. Call 425-297-5500 or see www.cancerpartnership.org for more information: Click on "Support Services," then, on the right side of the page, click on "Classes" or "Support Groups." | Pottstown YMCA presents Pink Confetti The Community Connection Tue, 01 May 2012 05:53 AM PDT Nearly a year ago, staff members at the Freedom Valley YMCA, which includes branches in Phoenixville, Spring Valley, Audobon and Pottstown, met to discuss the growing need to address the issues surrounding breast cancer and more specifically, what they could do to help survivors. | Cancer drug released to dying mom after video plea CTV.ca Tue, 01 May 2012 05:46 AM PDT A drug maker has decided to release a still-unapproved cancer medication to a U.S. woman with terminal breast cancer, after being inundated with phone calls from people who wanted to help the woman try to live a little longer. | Combination of Lenalidomide and SNS01-T Effective in Cancer Model Business Wire Tue, 01 May 2012 05:41 AM PDT BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (âSenescoâ or the âCompanyâ) (NYSE AMEX: SNT) announced today that a high level of tumor eradication in a mouse model of human multiple myeloma was achieved with a combination of SNS01-T and lenalidomide. âSNS01-T has once again demonstrated excellent efficacy alone and even more when combined with lenalidomide,â said Leslie J ... | | |
|